IBio (IBIO) on Friday filed a preliminary prospectus for the sale of up to around 11.3 million shares of its common stock by certain selling stockholders.
The shares are issuable upon the exercise of warrants sold to the selling stockholders in a private placement completed on April 30, the company said.
The warrants have an exercise price of $0.86 per share and will expire five years after issuance, iBio said.
The company said that it will not receive any of the proceeds from the sale of the shares, but will receive approximately $9.7 million in cash if the warrants are exercised in full. This will be used for working capital and general corporate purposes, the company added.
Shares of iBio were down 5.8% in recent trading Friday.
Price: 0.97, Change: -0.06, Percent Change: -5.83
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。